UR Home
![]() | Up a level |
, Schliemann, C., Stelljes, M., Balleisen, L., Maschmeyer, G., Grüneisen, A., Eimermacher, H., Giagounidis, A., Rasche, H., Hehlmann, R., Lengfelder, E., Thiel, E., Reichle, A., Aul, C., Ludwig, W.-D., Kern, W., Haferlach, T., Köpcke, W., Görlich, D., Sauerland, M. C., Heinecke, A., Wörmann, B. J., Hiddemann, W. and Büchner, T.
(2016)
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Leukemia 30 (6), pp. 1230-1236.
Fulltext not available.
, Schelker, R., Klobuch, S., Zaiss, S., Troppmann, M., Rehli, M.
, Haferlach, T., Herr, W. and Reichle, A.
(2015)
Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia.
Haematologica 100 (1), e4-e6.
Fulltext not available.
, Berdel, W. E., Braess, J., Spiekermann, K., Wörmann, B., Sauerland, M.-C., Heinecke, A., Hiddemann, W., Hehlmann, R. and Büchner, T.
(2009)
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
Leukemia 23 (12), pp. 2248-2258.
Fulltext not available.
Publication Server
Publishing: oa@ur.de
0941 943 -4239 or -69394
Dissertations: dissertationen@ur.de
0941 943 -3904
Research data: datahub@ur.de
0941 943 -5707